Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Web Exclusives
Symptomatic hypoglycemia increases risk of cardiovascular events, death in type 2 diabetes
Read More
FDA Approvals
Xofigo (Radium Ra 223 Dichloride): The First Alpha Particle–Emitting Radioactive Agent for the Treatment of Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases
Read More
FDA Approvals
Kadcyla (Ado-Trastuzumab Emtansine): First Antibody-Drug Conjugate Approved for the Treatment of HER2-Positive Metastatic Breast Cancer
Read More
New report addresses hypoglycemia and its impact on patients with diabetes
Read More
Most Americans with prediabetes are unaware that they have it
Read More
Intensive glycemic control reduces end-stage renal disease in type 2 diabetes
Read More
Achieving glucose, blood pressure, and lipid targets improving among diabetic patients, but there’s still long way to go
Read More
Cardiometabolic Health
Cardiovascular data confirm metformin over sulfonylurea as initial treatment choice in type 2 diabetes
Read More
Does insulin increase the risk of type 2 diabetes-related complications?
Read More
Measuring Coronary Calcium in Patients with Type 2 Diabetes Improves CVD Risk Assessment
Read More
25
26
27
28
29
30
31
Page 28 of 37
Results 271 - 280 of 364